|
Search
Collections
Benchmarks
Upload document
Organization
Zheng Yabing
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
Clinical trial
Phase II Clinical Study of Trastuzumab Emtansine (T-DM1) Combined With Cyclin-dependent Kinase 4/6 (CDK4/6) Inhibitor Ribociclib in the Treatment of Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Advanced Breast Cancer
Status:
, Estimated PCD: 2027-01-10